Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170,107,714
-
Total 13F shares
-
96,269,604
-
Share change
-
+1,754,784
-
Total reported value
-
$3,056,562,395
-
Put/Call ratio
-
30%
-
Price per share
-
$31.75
-
Number of holders
-
182
-
Value change
-
+$57,829,247
-
Number of buys
-
79
-
Number of sells
-
82
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q4 2014
As of 31 Dec 2014,
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) was held by
182 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,269,604 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Fund Advisors, Viking Global Investors LP, JENNISON ASSOCIATES LLC, JANUS CAPITAL MANAGEMENT LLC, WADDELL & REED FINANCIAL INC, and BlackRock Institutional Trust Company, N.A..
This page lists
182
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.